IQ-AI LIMITED IQ-AI Limited Share Price Deutsche Boerse AG
Equities
5Y1
JE00BD4H0R42
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.009 EUR | +12.50% |
|
+38.46% | -76.62% |
| 23/05 | Celadon ships to US; Oxford BioDynamics-Goodbody pact | AN |
| 20/05 | IQ-AI subsidiary gets second FDA rare paediatric disease designation | AN |
| Sales 2022 | 536K 683K 629K 56.95M | Sales 2023 | 609K 776K 716K 64.76M | Capitalization | 8.96M 11.42M 10.52M 952M |
|---|---|---|---|---|---|
| Net income 2022 | - 0 0 0 | Net income 2023 | - 0 0 0 | EV / Sales 2022 | 5.75 x |
| Net cash position 2022 | 252K 321K 296K 26.76M | Net cash position 2023 | 139K 177K 163K 14.74M | EV / Sales 2023 | 14.5 x |
| P/E ratio 2022 |
-6.52
x | P/E ratio 2023 |
-13.8
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 61.72% |
More Fundamentals
* Assessed data
More news
| 1 day | +12.50% | ||
| 1 week | +38.46% | ||
| 3 months | -28.00% | ||
| 6 months | -73.91% | ||
| Current year | -76.62% |
1 week
0.01
0.01
1 month
0.010.01
Current year
0.010.05
1 year
0.010.06
3 years
0.000.11
5 years
0.000.11
10 years
0.000.11
| Managers | Title | Age | Since |
|---|---|---|---|
Trevor Brown
CEO | Chief Executive Officer | 78 | 13/15/13 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Trevor Brown
CEO | Chief Executive Officer | 78 | 13/15/13 |
Vinod Kaushal
BRD | Director/Board Member | 60 | 20/17/20 |
| Director/Board Member | - | 18/19/18 |
| Date | Price | Change |
|---|---|---|
| 31/24/31 | 0.009 | +12.50% |
| 30/24/30 | 0.008 | +23.08% |
| 29/24/29 | 0.0065 | -.--% |
| 28/24/28 | 0.0065 | -.--% |
| 27/24/27 | 0.0065 | -.--% |
Delayed Quote Deutsche Boerse AG, May 31, 2024 at 02:27 pm IST
More quotes
IQ-AI Limited is a Jersey-based company, which is engaged in the provision of clinical treatments to patients in the field of medical imaging diagnostics, based on technology. The Company operates through two segments: holding company expenses and medical software. Its subsidiaries include Imaging Biometrics, LLC and Stone Checker Software Limited. Imaging Biometrics, LLC is a healthcare imaging software company. In addition to providing regulatory consulting services, Imaging Biometrics, LLC supplies medical technology solutions and has a neuroimaging product portfolio. Stone Checker Software Limited is a supplier of technology solutions in the field of kidney stone analysis and kidney stone prevention.
Calendar
16/09/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -24.16% | 7.76B | |
| +68.65% | 4.33B | |
| -2.98% | 2.64B | |
| +2.72% | 2.63B | |
| -46.17% | 2.16B | |
| -15.27% | 1.75B | |
| -22.12% | 1.46B | |
| +13.62% | 1.17B | |
| -43.81% | 1.14B |
- Stock Market
- Equities
- IQAI Stock
- 5Y1 Stock
